drugset / Trial / NCT03497897
Study to Assess the Efficacy and Safety of LYS006 in Patients With Moderate to Severe Inflammatory Acne
RandomizedParallel-groupDouble-blindTreatment
Summary
The main purpose of this study is to assess preliminary efficacy and safety of LYS006 in patients with moderate to severe inflammatory acne and to determine if LYS006 has an adequate clinical profile for further clinical development.
Timeline
- Start
- 2018-09-10
- Primary completion
- 2022-02-24
- Completion
- 2022-03-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LYS006 | Unknown | 2 mg | Oral |
| Subject | LYS006 | Unknown | 20 mg | Oral |